Back
Invesco FTSE RAFI Dev Mkts ex-US ETF Vs. Cytokinetics Industry Stock Comparison
Sell
38
PXF
Invesco FTSE RAFI Dev Mkts ex-US ETF
Last Price:
48.79
Seasonality Move:
-1.28%
Buy
55
CYTK
Cytokinetics
Last Price:
53.96
Seasonality Move:
7.55%
Sell
38
Invesco FTSE RAFI Dev Mkts ex-US ETF (PXF)
is a Sell
Is Invesco FTSE RAFI Dev Mkts ex-US ETF a Buy, Sell or Hold?
- The current Invesco FTSE RAFI Dev Mkts ex-US ETF [PXF] share price is $48.76. The Score for PXF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- PXF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PXF Stock Price Chart
What is Invesco FTSE RAFI Dev Mkts ex-US ETF's stock price today?
-
The Invesco FTSE RAFI Dev Mkts ex-US ETF share price today is $48.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PXF is experiencing slight buying pressure.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $53.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.
PXF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 36.81 | Sell |
| Chaikin Money Flow: | 11562 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.85 - 51.01) | Sell |
| Bollinger Bands (100): | (47.53 - 50.23) | Sell |
CYTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.04 | Sell |
| Relative Strength Index (14 RSI): | 46.58 | Sell |
| Chaikin Money Flow: | 781761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.51 - 58.99) | Sell |
| Bollinger Bands (100): | (57.71 - 76.51) | Sell |
PXF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.93 | Sell |
| 20-day SMA: | 50.37 | Sell |
| 50-day SMA: | 49.71 | Sell |
| 200-day SMA: | 46.84 | Buy |
| 8-day EMA: | 49.72 | Sell |
| 20-day EMA: | 50.06 | Sell |
| 50-day EMA: | 49.75 | Sell |
| 200-day EMA: | 47.55 | Buy |
CYTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.47 | Buy |
| 20-day SMA: | 52.83 | Buy |
| 50-day SMA: | 60.85 | Sell |
| 200-day SMA: | 55.3 | Sell |
| 8-day EMA: | 53.07 | Buy |
| 20-day EMA: | 54.08 | Sell |
| 50-day EMA: | 58.8 | Sell |
| 200-day EMA: | 57.11 | Sell |
Invesco FTSE RAFI Dev Mkts ex-US ETF Earnings Growth & PXF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.
Invesco FTSE RAFI Dev Mkts ex-US ETF Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cytokinetics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||